FHLT Stock Overview
Future Health ESG Corp. does not have significant operations.
Future Health ESG Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$10.01|
|52 Week High||US$10.84|
|52 Week Low||US$9.75|
|1 Month Change||0.65%|
|3 Month Change||1.21%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||1.41%|
Recent News & Updates
|FHLT||US Capital Markets||US Market|
Return vs Industry: Insufficient data to determine how FHLT performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how FHLT performed against the US Market.
|FHLT Average Weekly Movement||n/a|
|Capital Markets Industry Average Movement||0.4%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: Insufficient data to determine FHLT's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine FHLT's volatility change over the past year.
About the Company
Future Health ESG Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue an initial business combination opportunity in the smart health technology sector.
Future Health ESG Fundamentals Summary
|FHLT fundamental statistics|
Is FHLT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|FHLT income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.048|
|Net Profit Margin||0.00%|
How did FHLT perform over the long term?See historical performance and comparison
Is FHLT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FHLT?
Other financial metrics that can be useful for relative valuation.
|What is FHLT's n/a Ratio?|
Price to Book Ratio vs Peers
How does FHLT's PB Ratio compare to its peers?
|FHLT PB Ratio vs Peers|
|Company||PB||Estimated Growth||Market Cap|
ASCB A SPAC II Acquisition
SAR Saratoga Investment
ATAK Aurora Technology Acquisition
ASA ASA Gold and Precious Metals
FHLT Future Health ESG
Price-To-Book vs Peers: FHLT is good value based on its Price-To-Book Ratio (-30x) compared to the peer average (7105.6x).
Price to Earnings Ratio vs Industry
How does FHLT's PE Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Book vs Industry: FHLT is good value based on its Price-To-Book Ratio (-30x) compared to the US Capital Markets industry average (-23.4x)
Price to Book Ratio vs Fair Ratio
What is FHLT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PB Ratio||-30x|
|Fair PB Ratio||n/a|
Price-To-Book vs Fair Ratio: Insufficient data to calculate FHLT's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of FHLT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate FHLT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate FHLT's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
- Take a look at our analysis of FHLT's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
How is Future Health ESG forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Diversified Financials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Future Health ESG has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of FHLT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
How has Future Health ESG performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical Diversified Financials annual earnings growth
Earnings and Revenue History
Quality Earnings: FHLT is currently unprofitable.
Growing Profit Margin: FHLT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if FHLT's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare FHLT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FHLT is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (33.2%).
Return on Equity
High ROE: FHLT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Discover strong past performing companies
How is Future Health ESG's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: FHLT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: FHLT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: FHLT is debt free.
Reducing Debt: FHLT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FHLT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: FHLT has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 178.9% each year.
Discover healthy companies
What is Future Health ESG current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|Future Health ESG Dividend Yield vs Market|
|Company (Future Health ESG)||n/a|
|Market Bottom 25% (US)||1.7%|
|Market Top 25% (US)||4.7%|
|Industry Average (Capital Markets)||3.0%|
|Analyst forecast in 3 Years (Future Health ESG)||n/a|
Notable Dividend: Unable to evaluate FHLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate FHLT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if FHLT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if FHLT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as FHLT has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Brad Bostic (47 yo)
Mr. Bradley A. Bostic also known as Brad, serves as Chairman and Chief Executive Officer at Future Health ESG Corp. since February 25, 2021. He had been Director of Novus Capital Corporation since March 5,...
Experienced Board: FHLT's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Future Health ESG Corp.'s employee growth, exchange listings and data sources
- Name: Future Health ESG Corp.
- Ticker: FHLT
- Exchange: NasdaqCM
- Founded: 2021
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Implied Market Cap: US$250.250m
- Shares outstanding: 25.00m
- Website: https://www.fhesg.com
- Future Health ESG Corp.
- 8 The Green
- Suite 12081
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|FHLT.U||NasdaqCM (Nasdaq Capital Market)||Units||US||USD||Sep 2021|
|FHLT||NasdaqCM (Nasdaq Capital Market)||Yes||Common Stock||US||USD||Dec 2021|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/01 00:00|
|End of Day Share Price||2022/09/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.